2010•The FASEB JournalRequires access

Determination of the drug binding site within integrin CD11b/CD18

Keith Rands, Darren G. Stoub, Vineet Gupta

Open publisher page 0 citations

Abstract

α/β integrin heterodimers are cell surface proteins involved in cellular communication. The integrin CD11b/CD18 is the predominant integrin found in neutrophils, macrophages and monocoytes and has been implicated as a signaling protein for the inflammation response. Recently, a class of small molecule drugs that activate the integrin CD11b/CD18 was reported. Using molecular docking experiments and site‐directed mutagenesis, we have identified a putative drug binding site in the ligand‐binding aA domain of CD11b, which suggest an allosteric activation of the integrin.

About this research paper

What this paper is about

α/β integrin heterodimers are cell surface proteins involved in cellular communication. The integrin CD11b/CD18 is the predominant integrin found in neutrophils, macrophages and monocoytes and has been implicated as a signaling protein for the inflammation response. Recently, a class of small molecule drugs that activate the integrin CD11b/CD18 was reported. Using molecular docking experiments and site‐directed mutagenesis, we have identified a putative drug binding site in the ligand‐binding aA domain of CD11b, which suggest an allosteric activation of the integrin.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

α/β integrin heterodimers are cell surface proteins involved in cellular communication. The integrin CD11b/CD18 is the predominant integrin found in neutrophils, macrophages and monocoytes and has been implicated as a signaling protein for the inflammation response. Recently, a class of small molecule drugs that activate the integrin CD11b/CD18 was reported. Using molecular docking experiments and site‐directed mutagenesis, we have identified a putative drug binding site in the ligand‐binding aA domain of CD11b, which suggest an allosteric activation of the integrin.

Key concepts: Integrin alpha M, CD18, Integrin, Allosteric regulation, Integrin, beta 6, Cell biology, Chemistry, Binding site

Related papers

Back to paper searchBrowse research topicsOriginal source
Determination of the drug binding site within integrin CD11b/CD18 — Research Paper | ScholarLens